Document is current

Article History

Received: 31 December 2024

Accepted: 14 April 2025

First Online: 6 May 2025

Declarations

:

: The study received approval from the Ethikkomission of the International Psychoanalytic University of Berlin (EKIPU; No. 2023_05). Any amendments to the protocol that could affect the study’s conduct, patient benefits, or safety are formally documented. Three amendments (amendments 1 on 05.06.23; 2 on 01.11.23;3 on 08.01.24) have been submitted and approved by the Ethikkomission (see appendix D for further details). Voluntary participation is a core principle in this study. Potential participants are provided with comprehensive information and allowed adequate time for deliberation. Digital informed consent is obtained from those willing to participate, and participants can withdraw their consent at any time. If consent is revoked, the participants’ data are anonymised, and they are removed from the study while retaining access to the growth path or listener training.

: Not applicable.

: Gunther Meinlschmidt (G.M.2) received funding from the Stanley Thomas Johnson Stiftung & Gottfried und Julia Bangerter-Rhyner-Stiftung under projects no. PC 28/17 and PC 05/18, from Gesundheitsförderung Schweiz under project no. 18.191/K50001, from the Swiss Heart Foundation under project no. FF21101, from the Research Foundation of the International Psychoanalytic University (IPU) Berlin under projects no. 5087 and 5217, from the Swiss National Science Foundation (SNSF) under project no. 100014_135328, from the German Federal Ministry of Education and Research under budget item 68606, from the Hasler Foundation under project No. 23004, in the context of a Horizon Europe project from the Swiss State Secretariat for Education, Research and lnnovation (SERI) under contract number 22.00094, and from Wings Health in the context of a proof-of-concept study. GM is a co-founder, member of the board, and shareholder of Therayou AG, active in digital and blended mental healthcare. GM receives royalties from publishing companies as author, including a book published by Springer, and an honorarium from Lundbeck for speaking at a symposium. Furthermore, GM is compensated for providing psychotherapy to patients, acting as a supervisor, serving as a self-experience facilitator (‘Selbsterfahrungsleiter’), and for postgraduate training of psychotherapists, psychosomatic specialists, and supervisors. Glen Moriarty (G.M.1) is the founder and CEO of 7 Cups. ATA is employed by 7 Cups. There are no further potential competing interests to declare.

: During the preparation of this work, the author(s) used Co-pilot in order to help prepare the outline for the protocol. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.